Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-30

Clinical Trial Update: Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia [NA]

View source ↗

Summary

This clinical trial update examines susceptibility to infections, tumor risk, and liver disease in patients with Ataxia Telangiectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Ataxia Telangiectasia | NA | Status: UNKNOWN